• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析素作为心血管疾病中抗炎的介质。

Resolvins as proresolving inflammatory mediators in cardiovascular disease.

机构信息

Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, E-07122 Palma de Mallorca, Balearic Islands, Spain.

Nutrition and Dietetics Department, School of Pharmacy, University of Concepción, 4070386 Concepción, VIII - Bio Bio Region, Chile.

出版信息

Eur J Med Chem. 2018 Jun 10;153:123-130. doi: 10.1016/j.ejmech.2017.07.018. Epub 2017 Jul 13.

DOI:10.1016/j.ejmech.2017.07.018
PMID:28732558
Abstract

Cardiovascular disease (CVD) represents a global burden with a prevalence that continues increasing progressively. CVD comprises a group of disorders of the heart and blood vessels including coronary heart disease, cerebrovascular disease and peripheral arterial disease. This group of disorders is associated with an inflammatory process which can participate in the pathophysiology of these diseases. Inflammation resolution is an active process involving the participation of pro-resolving mediators such as lipoxins, resolvins, protectins and maresins. Pro-resolving mediators are bioactive molecules generated from omega-3 polyunsaturated fatty acids (PUFAs); among these eicosapentaenoic acid (EPA; C20:5n3) and docosahexaenoic acid (DHA; C22:6n3) are the precursors of resolvins. Pro-resolving mediators orchestrate the correct resolution of inflammation and also stimulate tissue regeneration. Their deregulation can lead to chronic inflammation involving CVD. The discovery of these novel lipid mediators opens a new range of possibilities for the design of anti-inflammatory agents with therapeutic potential for a wide variety of diseases. The present work summarizes the available data about the general characteristics, structure and biosynthesis of resolvins and their relation as protective compounds in CVD.

摘要

心血管疾病(CVD)是一种全球性疾病,其患病率呈持续上升趋势。CVD 包括一组与心脏和血管有关的疾病,包括冠心病、脑血管病和外周动脉疾病。这组疾病与炎症过程有关,炎症过程可能参与这些疾病的病理生理学。炎症解决是一个涉及参与促解决介质(如脂氧素、 resolvins、保护素和maresins)的主动过程。促解决介质是由ω-3 多不饱和脂肪酸(PUFA)生成的生物活性分子;其中二十碳五烯酸(EPA;C20:5n3)和二十二碳六烯酸(DHA;C22:6n3)是 resolvins 的前体。促解决介质协调炎症的正确解决,同时刺激组织再生。它们的失调可能导致涉及 CVD 的慢性炎症。这些新型脂质介质的发现为设计具有治疗多种疾病潜力的抗炎药物开辟了新的可能性。本工作总结了关于 resolvins 的一般特征、结构和生物合成及其在 CVD 中作为保护化合物的关系的现有数据。

相似文献

1
Resolvins as proresolving inflammatory mediators in cardiovascular disease.解析素作为心血管疾病中抗炎的介质。
Eur J Med Chem. 2018 Jun 10;153:123-130. doi: 10.1016/j.ejmech.2017.07.018. Epub 2017 Jul 13.
2
Resolvins: Current understanding and future potential in the control of inflammation.消退素:炎症控制方面的当前认识与未来潜力
Curr Opin Drug Discov Devel. 2009 Sep;12(5):644-58.
3
Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?ω-3 多不饱和脂肪酸在危重病中的作用:抗炎、促解决,还是两者兼有?
Oxid Med Cell Longev. 2017;2017:5987082. doi: 10.1155/2017/5987082. Epub 2017 Jun 14.
4
Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis.二十碳五烯酸和二十二碳六烯酸衍生的消退素作为关节炎治疗药物的意义。
Eur J Pharmacol. 2016 Aug 15;785:165-173. doi: 10.1016/j.ejphar.2015.05.072. Epub 2015 Jul 9.
5
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.E 系列消退素代谢组、专门的促消退介质(SPM)的生物合成及其立体化学在炎症消退中的关键作用:为长期新冠、人体临床试验和靶向精准营养制备 SPM。
Semin Immunol. 2022 Jan;59:101597. doi: 10.1016/j.smim.2022.101597. Epub 2022 Feb 16.
6
Novel chemical mediators in the resolution of inflammation: resolvins and protectins.炎症消退过程中的新型化学介质:消退素和保护素。
Anesthesiol Clin. 2006 Jun;24(2):341-64. doi: 10.1016/j.atc.2006.01.003.
7
Omega-3 fatty acids and inflammatory processes: from molecules to man.欧米伽-3脂肪酸与炎症过程:从分子到人体
Biochem Soc Trans. 2017 Oct 15;45(5):1105-1115. doi: 10.1042/BST20160474. Epub 2017 Sep 12.
8
Resolvins and protectins: mediating solutions to inflammation.消退素和保护素:介导炎症的解决方法
Br J Pharmacol. 2009 Oct;158(4):960-71. doi: 10.1111/j.1476-5381.2009.00290.x. Epub 2009 Jul 7.
9
Lipoxins and resolvins in inflammatory bowel disease.炎症性肠病中的脂氧素和消退素
Inflamm Bowel Dis. 2007 Jun;13(6):797-9. doi: 10.1002/ibd.20109.
10
Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators.控制急性炎症的消退:一类新型的兼具抗炎和促消退作用的介质
J Periodontol. 2008 Aug;79(8 Suppl):1520-6. doi: 10.1902/jop.2008.080231.

引用本文的文献

1
The Involvement of Resolvins in Pathological Mechanisms of Periodontal Disease Associated with Type 2 Diabetes: A Narrative Review.消退素在2型糖尿病相关牙周病病理机制中的作用:一项叙述性综述
Int J Mol Sci. 2024 Nov 28;25(23):12784. doi: 10.3390/ijms252312784.
2
Relationship between Polyunsaturated Fatty Acid Metabolism and Atherosclerosis.多不饱和脂肪酸代谢与动脉粥样硬化之间的关系。
Rev Cardiovasc Med. 2024 Apr 9;25(4):142. doi: 10.31083/j.rcm2504142. eCollection 2024 Apr.
3
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease.
血管炎症和动脉粥样硬化性心血管疾病中的特异性促解决介质。
Nat Rev Cardiol. 2024 Nov;21(11):808-823. doi: 10.1038/s41569-023-00984-x. Epub 2024 Jan 12.
4
Interface between Resolvins and Efferocytosis in Health and Disease.解析物与吞噬作用在健康与疾病中的相互作用。
Cell Biochem Biophys. 2024 Mar;82(1):53-65. doi: 10.1007/s12013-023-01187-4. Epub 2023 Oct 4.
5
Plasma Fatty Acid Composition, Oxidative and Inflammatory Status, and Adherence to the Mediterranean Diet of Patients with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的血浆脂肪酸组成、氧化和炎症状态以及对地中海饮食的依从性
Antioxidants (Basel). 2023 Aug 3;12(8):1554. doi: 10.3390/antiox12081554.
6
Future applications of exosomes delivering resolvins and cytokines in facilitating diabetic foot ulcer healing.递送消退素和细胞因子的外泌体在促进糖尿病足溃疡愈合方面的未来应用。
World J Diabetes. 2023 Jan 15;14(1):35-47. doi: 10.4239/wjd.v14.i1.35.
7
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.特异性促解决脂质介质:动脉粥样硬化的潜在治疗靶点。
Int J Mol Sci. 2022 Mar 15;23(6):3133. doi: 10.3390/ijms23063133.
8
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders.新型脲丙酰胺类化合物作为靶向中枢神经系统疾病炎症消退的 FPR2 激动剂的设计、合成、生物学评价及计算研究
J Med Chem. 2022 Mar 24;65(6):5004-5028. doi: 10.1021/acs.jmedchem.1c02203. Epub 2022 Mar 8.
9
A Deeper Assessment of ω3-Poly-Unsaturated Fatty Acids in Polycystic Ovary Syndrome Management. Comment on Regidor et al. Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response. 2021, , 384.更深入评估ω3 多不饱和脂肪酸在多囊卵巢综合征管理中的作用。评 Regidor 等人的文章:多囊卵巢综合征中的慢性炎症:特殊的促解决脂质介质 (SPM) 在改善解决反应中的潜在益处。2021 年, ,384 页。
Int J Mol Sci. 2021 Sep 18;22(18):10114. doi: 10.3390/ijms221810114.
10
Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review.天然分子在多囊卵巢综合征 (PCOS) 管理中的作用:分析性综述。
Nutrients. 2021 May 15;13(5):1677. doi: 10.3390/nu13051677.